Navigation Links
11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions
Date:12/4/2008

CINCINNATI, Dec. 4 /PRNewswire/ -- Dr. Stephen Joffe, Craig Joffe, and Alan Buckey today filed an amendment to their Schedule 13D with the U.S. Securities and Exchange Commission. The group previously filed a 13D disclosing ownership of 11.4% of LCA-Vision, Inc. (Nasdaq: LCAV), which operates 77 LasikPlus fixed-site laser vision correction centers in 33 states in the United States. Dr. Joffe is the founder and former Chairman and CEO of LCAV. Craig Joffe is the former Chief Operating Officer and General Counsel of LCAV, and Alan Buckey is the former Executive Vice President of Finance and Chief Financial Officer of the Company. The three of them worked together as the executive management team of LCAV (Nasdaq: LCAV) to grow the market capitalization of the Company well in excess of 1,000% from 2003-2006.

In a letter, dated December 4, 2008, to Tony Woods and the other members of the Board of Directors of LCA-Vision, the group stated they were "perplexed" by the Board's failure to solicit their help saving the Company from its current path of self-destruction. Given the Company's dire condition and poor prognosis, coupled with the group's impeccable credentials at growing shareholder value at the Company, the group realized the "disconnect" may be the Board's need for further clarity on specifically how the group could help.

In the letter, the group states, "The three of us believe we can add tremendous value to the Company, its shareholders, and its physicians and employees by providing us Board representation and reappointing us to executive management positions in the Company. We have no doubt we can help provide the strategic vision the Company needs today, and have the experience and expertise to execute that strategy
'/>"/>

SOURCE Steve Joffe
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. 11.4% Shareholders & Former Executive Management of LCA-Vision Express Shock and Disbelief at Recent Adoption of Poison Pill
2. Dynamics Research Corporation Awarded $11.4 Million Medical Healthcare Program Management Contract
3. Senator Norm Coleman Praised for Leading Successful Effort to Derail $11.4 Million Minnesota Medicare Cuts
4. NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder
5. The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders
6. Barr Shareholders Approve Pending Teva Acquisition
7. Cord Blood America Posts Letter to Shareholders: New Administrations Potential Enhanced Stem Cell Research Initiative Should Benefit the Company and Its Shareholders
8. Lees Pharmaceutical Kept Up the Rapid Pace of Growth; Profit Attributable to Shareholders Surged 176% in the Nine Months of 2008
9. MaxLife Fund Corp. declares dividends to shareholders of Preferred Shares
10. Westaim terminates reorganization agreement and cancels shareholders meeting
11. GeneThera - CHANGING DIRECTIONS - an Update to Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Royal River Natural Foods, a locally-owned independent natural health ... the amino acid creatine, which athletes typically use to build ... , The report is part of the April ... which Royal River Natural Foods publishes each month as a ... latest in nutrition science. Also in the April issue, vitamin ...
(Date:4/1/2015)... One year ago today, the USO cut ... in the United States and changed the landscape on Naval ... facility has served more than 100,000 troops and military families ... wounded, ill and injured and their families, proving to be ... medical centers in the country. After opening its doors on ...
(Date:4/1/2015)... 2015 Bird B Gone, the leader ... applications now offers a complete line of Bird ... bird netting products quickly, safely and efficiently. , Having ... any bird netting installation. It’s important to determine exactly ... of a project. This includes deciding whether to use ...
(Date:4/1/2015)... 24, 2015 (PRWEB) April 01, 2015 The ... the most extreme jungle adventure you could ever embark upon. ... 23 days. Endorsed by the Philippine Department of Tourism, these ... visited the rainforest, but very few people have ever been ... Adventure Officer. , Armed with nothing more than a backpack ...
(Date:4/1/2015)... New Jersey Governor First Spouse Mary ... from across the country in sponsoring the “Light ... Down Syndrome Day(WDSD), to increase awareness of, and ... Down syndrome cognition research. , In addition to ... Samoa, Arizona, California, Colorado, Delaware, Florida, Guam, Hawaii, ...
Breaking Medicine News(10 mins):Health News:New Study Finds Strength-Building Supplement Improves Circulation, Retailer Reports 2Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 2Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 3Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 4Health News:USO’s Warrior and Family Center at Bethesda Marks First Anniversary and More than 100,000 Servicemen and Women Served 5Health News:Bird B Gone Now Carries Complete Bird Netting Hardware 2Health News:Bird B Gone Now Carries Complete Bird Netting Hardware 3Health News:Governor First Spouses Join with New Jersey First Lady Mary Pat Christie to Support Advances in Biomedical Research to Treat Down Syndrome Cognitive Impairment 2
... Brun, fierce mental health advocate for hurricane-traumatized children, is ... Sister Judith Brun, CSJ, who has worked tirelessly to ... still suffering hurricane-induced trauma in Louisiana, will address the ... Commencement on June 7. , , Brun,s ...
... , , HAE:TSX, ... , MONTREAL, June 3 /PRNewswire-FirstCall/ - Haemacure Corporation ... and Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX:ANP) ... Angiotech to Haemacure in a minimum amount of US$2.5 ...
... The SSI Group, Inc. (SSI) announced their success in ... Health System (DUHS) and its affiliated hospitals for a ... the primary supplier of claims management products, including but not ... functionality of posting back billing information to the host HIS ...
... A University of Toronto study provides the first direct evidence ... filters our perceptual experience suggesting that seeing the world through ... and bad moods literally change the way our visual cortex ... of T professor of psychology. "Specifically our study shows ...
... An over-the-counter prostate cancer test kit could be coming to ... a University of Central Florida chemist and M.D. Anderson Cancer ... M.D. Anderson-Orlando,s Dr. Cheryl Baker and Jimmie Colon teamed up ... wanted to develop an effective, inexpensive test to screen for ...
... new review published in the Journal of Human Nutrition ... a beneficial effect on the prevention of prostate cancer. Results ... and high in fruits and vegetables is beneficial in preventing ... K. Chapman conducted an evidence-based review of dietary recommendations in ...
Cached Medicine News:Health News:Three New Programs Confer Degrees at MSPP Graduation on June 7, 2009 2Health News:Three New Programs Confer Degrees at MSPP Graduation on June 7, 2009 3Health News:Three New Programs Confer Degrees at MSPP Graduation on June 7, 2009 4Health News:Haemacure and Angiotech Enter License, Distribution and Supply Agreements for Haemacure's All-Human Fibrin Sealant and Thrombin Products 2Health News:Haemacure and Angiotech Enter License, Distribution and Supply Agreements for Haemacure's All-Human Fibrin Sealant and Thrombin Products 3Health News:Haemacure and Angiotech Enter License, Distribution and Supply Agreements for Haemacure's All-Human Fibrin Sealant and Thrombin Products 4Health News:Duke University Health System Chooses SSI for Revenue Cycle Claims Management 2Health News:Duke University Health System Chooses SSI for Revenue Cycle Claims Management 3Health News:People who wear rose-colored glasses see more, University of Toronto study shows 2Health News:Effective over-the-counter prostate cancer test kit likely in next few years 2
(Date:4/1/2015)...  Medelita® has renewed a commitment to identify top ... who have exhibited leadership in their communities and ... year, "The Right Fit H.E.R.O. Honorarium" saw over 200 ... to 10 through a series of criteria, including an ... colleagues in medicine, friends, and family.  In its second ...
(Date:4/1/2015)... Mar. 30, 2015 Research and Markets ... of the "Medical Device Studies: Clinical Evidence" ... course has been designed specifically for those who ... medical devices and in-vitro diagnostic products. Clinical data ... emphasis on high quality, appropriate clinical evidence has ...
(Date:4/1/2015)... 2015  Egalet Corporation (Nasdaq: EGLT ) ... on developing, manufacturing and marketing innovative pain treatments, ... $60.0 million aggregate principal amount of its convertible ... private placement to qualified institutional buyers pursuant to ... as amended (the "Act"). Egalet also granted the ...
Breaking Medicine Technology:Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 2Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 3Second Annual $25,000 Honorarium for Exceptional Medical Residents to Accept Nominations in April 2015 4Medical Device Studies: Clinical Evidence Seminar - London, UK, 13th, 14th of May 2015 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020 7
... ONCONASE for,Treatment of Neuroblastoma, BLOOMFIELD, N.J., June ... that new data show ONCONASE,the company's lead ... neuroblastoma cells. , The pre-clinical in vitro ... (2007; Vol. 250, Issue 1: 107-116) through ...
... YORK--(BUSINESS WIRE)--Jun 27, 2007 - Gentium S.p.A. ... and preclinical,data that support the safety, activity, ... in combination with anticancer,therapy in multiple myeloma. ... ongoing Phase I/II clinical trial for patients,with ...
Cached Medicine Technology:In Vitro and In Vivo Data Show Alfacell's Onocanse is Active,Against Naive and Chemoresistant Neuroblastoma Cells 2In Vitro and In Vivo Data Show Alfacell's Onocanse is Active,Against Naive and Chemoresistant Neuroblastoma Cells 3Gentium's Defibrotide Seen as Active in Multiple Myeloma 2Gentium's Defibrotide Seen as Active in Multiple Myeloma 3
... The 6060 MULTI-THERAPY Infusion ... of infusion profiles that ... reliable delivery. Designed for ... the 6060 MULTI-THERAPY Pump ...
... pumps can be customized with selectable performance ... sites and therapies. The COLLEAGUE pumps ... be used for both gravity and pump ... From simple infusions to medication therapies requiring ...
... Welcome to the Division of Pathology ... one of the nation's largest and most ... staff of nearly 700 employees and more ... generate over 7 million laboratory test results, ...
Focus Diagnostics Reference Laboratory is known for quality infectious disease and autoimmune testing services. We offer over 1200 tests and panels and are continually adding new tests to our menu....
Medicine Products: